Fluid biopsy for solid tumors: a patient’s companion for lifelong characterization of their disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fluid biopsy for solid tumors: a patient’s companion for lifelong characterization of their disease
Authors
Keywords
-
Journal
Future Oncology
Volume 8, Issue 8, Pages 989-998
Publisher
Future Medicine Ltd
Online
2012-08-16
DOI
10.2217/fon.12.91
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of CA 27.29 and circulating tumor cells before, at the end, and 2 years after adjuvant chemotherapy in patients with primary breast cancer: The SUCCESS trial.
- (2017) P. G. M. Hepp et al. JOURNAL OF CLINICAL ONCOLOGY
- High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis
- (2012) Jorge Nieva et al. PHYSICAL BIOLOGY
- Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line
- (2012) Daniel C Lazar et al. PHYSICAL BIOLOGY
- Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology
- (2012) Marco Wendel et al. PHYSICAL BIOLOGY
- Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors
- (2012) Edward H Cho et al. PHYSICAL BIOLOGY
- Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
- (2012) Dena Marrinucci et al. PHYSICAL BIOLOGY
- Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges
- (2011) E. S. Lianidou et al. CLINICAL CHEMISTRY
- Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
- (2011) Matthew G. Krebs et al. Journal of Thoracic Oncology
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Racial disparities in length of stay in hospice care by tumor stage in a large elderly cohort with non-small cell lung cancer
- (2011) Dale Hardy et al. PALLIATIVE MEDICINE
- The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients
- (2010) Lecia V. Sequist et al. Journal of Thoracic Oncology
- Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer
- (2010) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
- (2010) L. Pusztai et al. ONCOLOGIST
- Cytomorphology of Circulating Colorectal Tumor Cells: A Small Case Series
- (2010) Dena Marrinucci et al. Journal of Oncology
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
- (2009) V. C. Daniel et al. CANCER RESEARCH
- Personalized Medicine and Inhibition ofEGFRSignaling in Lung Cancer
- (2009) Adi F. Gazdar NEW ENGLAND JOURNAL OF MEDICINE
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation